International Journal of Molecular and Cellular Medicine最新文献

筛选
英文 中文
TNF-α and E-Selectin as Valuable Biomarkers in Patients with Acute Coronary Artery Syndrome. TNF-α和e -选择素作为急性冠状动脉综合征患者有价值的生物标志物
IF 0.8
International Journal of Molecular and Cellular Medicine Pub Date : 2025-07-01 eCollection Date: 2025-01-01 DOI: 10.22088/IJMCM.BUMS.14.2.694
Hassan Jabbar Auda, Ali Mohammed Barakat, Hassan Sarhan Sachet, Raed Fanoukh Aboqader, Adnan Taan Thamer
{"title":"TNF-α and E-Selectin as Valuable Biomarkers in Patients with Acute Coronary Artery Syndrome.","authors":"Hassan Jabbar Auda, Ali Mohammed Barakat, Hassan Sarhan Sachet, Raed Fanoukh Aboqader, Adnan Taan Thamer","doi":"10.22088/IJMCM.BUMS.14.2.694","DOIUrl":"10.22088/IJMCM.BUMS.14.2.694","url":null,"abstract":"<p><p>Coronary artery disease (CAD) remains the leading cause of mortality worldwide, especially in developing countries, with dyslipidemia being a major risk factor. This study aimed to evaluate lipid parameters and inflammatory biomarkers-E-selectin and tumor necrosis factor-alpha (TNF-α)-to understand their roles in the pathogenesis of acute coronary syndrome (ACS). A case-control design was used, involving 120 participants: 60 patients diagnosed with ACS and 60 healthy controls, enrolled between January and December 2024. Blood samples were analyzed to assess lipid profiles, including total cholesterol, triglycerides, HDL, LDL, and VLDL, using a SMART-120 chemistry analyzer. Serum levels of TNF-α and E-selectin were measured using enzyme-linked immunosorbent assay (ELISA). Results showed significant differences in lipid profiles between ACS patients and controls, supporting the impact of dyslipidemia on ACS development. E-selectin levels were significantly elevated in ACS patients (213.26 ± 2.72 pg/mL) compared to controls (175.11 ± 2.71 pg/mL), with P < 0.0001. Similarly, TNF-α levels were higher in patients (83.20 ± 3.88 pg/mL) than controls (45.65 ± 1.79 pg/mL), also with P < 0.0001. ROC curve analysis demonstrated that E-selectin had 96% sensitivity and specificity at a cutoff of 73.44 pg/mL, while TNF-α had 93% sensitivity and 86% specificity at a cutoff of 188.65 pg/mL. Both biomarkers positively correlated with body mass index (r = 0.572, P < 0.0001).The findings suggest that TNF-α and E-selectin are potential diagnostic biomarkers for ACS and play key <b><i>.</i></b></p>","PeriodicalId":14152,"journal":{"name":"International Journal of Molecular and Cellular Medicine","volume":"14 2","pages":"694-704"},"PeriodicalIF":0.8,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12321309/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144789074","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of the Antibacterial and Anti-Biofilm Activity of Chitosan-Arginine Nanoparticles and Sodium Fluoride against Streptococcus mutans. 壳聚糖-精氨酸纳米颗粒和氟化钠对变形链球菌的抗菌和抗生物膜活性评价。
IF 0.8
International Journal of Molecular and Cellular Medicine Pub Date : 2025-07-01 eCollection Date: 2025-01-01 DOI: 10.22088/IJMCM.BUMS.14.2.637
Fahimeh Daneshyar, Mohammad Yousef Alikhani, Soudeh Tayebi, Delaram Abedi Firouzjaei
{"title":"Evaluation of the Antibacterial and Anti-Biofilm Activity of Chitosan-Arginine Nanoparticles and Sodium Fluoride against <i>Streptococcus</i> <i>mutans</i>.","authors":"Fahimeh Daneshyar, Mohammad Yousef Alikhani, Soudeh Tayebi, Delaram Abedi Firouzjaei","doi":"10.22088/IJMCM.BUMS.14.2.637","DOIUrl":"10.22088/IJMCM.BUMS.14.2.637","url":null,"abstract":"<p><p>Dental caries is among the most prevalent chronic diseases. It arises from bacterial biofilm formation on tooth surfaces due to metabolic activity. <i>Streptococcus</i> <i>mutans</i> (<i>S</i>. <i>mutans</i>) is a key pathogen implicated in the development of dental caries. As bacterial resistance to conventional treatments increases, there is a growing interest in using novel compounds that possess antibacterial and antibiofilm properties. This study evaluated the effect of chitosan-arginine nanoparticles (CS-Arg NPs) and sodium fluoride (NaF) on inhibiting <i>S</i>. <i>mutans</i>' growth. After synthesizing CS-Arg NPs, their size, morphology, and chemical structure were evaluated. The broth microdilution method determined the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of CS-Arg NPs and NaF. The combined antibacterial and antibiofilm effect of CS-Arg NPs and NaF was assessed using the checkerboard method. The CS-Arg NPs had an average size of 269.9 nm with a zeta potential of +38.3 mV. The MIC of <i>S</i>. <i>mutans</i> for CS-Arg NPs and NaF was 312 µg/mL and 625 µg/mL, respectively, and the MBC for these NPs and NaF was 625 µg/mL and 2500 µg/mL, respectively. The fractional inhibitory concentration index (FICI) of the combination of CS-Arg NPs and NaF showed an additive effect (FICI = 1). The inhibitory effect of different concentrations of CS-Arg NPs and NaF, alone or in combination, on biofilm formation in the studied strain ranged from approximately 12% to 81%. This study demonstrated that CS-Arg NPs have antibacterial and antibiofilm properties against <i>S</i>. <i>mutans</i>, and their combination with NaF can enhance these antibacterial effects. These findings suggest that CS-Arg NPs and NaF, as a novel combination, could effectively develop oral hygiene products.</p>","PeriodicalId":14152,"journal":{"name":"International Journal of Molecular and Cellular Medicine","volume":"14 2","pages":"637-645"},"PeriodicalIF":0.8,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12321303/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144789037","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Colorectal Cancer; Novel Approaches in Chimeric Antigen Receptors (CAR) -T cell. 结直肠癌;嵌合抗原受体(CAR) -T细胞的新方法。
IF 0.8
International Journal of Molecular and Cellular Medicine Pub Date : 2025-07-01 eCollection Date: 2025-01-01 DOI: 10.22088/IJMCM.BUMS.14.2.777
Mahyar Haki, Mohammad Darvishi
{"title":"Colorectal Cancer; Novel Approaches in Chimeric Antigen Receptors (CAR) -T cell.","authors":"Mahyar Haki, Mohammad Darvishi","doi":"10.22088/IJMCM.BUMS.14.2.777","DOIUrl":"10.22088/IJMCM.BUMS.14.2.777","url":null,"abstract":"<p><p>Colorectal cancer (CRC) is a popular type of cancer, characterized by high mortality and a notable impression on the well-being of individuals. The success of adoptive chimeric antigen receptor T (CAR-T) cell therapy in treating hematological malignancies has been remarkable in recent years; however, its application in solid tumors like CRC has many challenges. These obstacles encompass the immunosuppressive microenvironment of the tumor, the insufficient targeting of CAR-T cells, the limited lifespan of CAR-T cells within the body, and the constrained capacity for proliferation. Additionally, CAR-T cells face hurdles in effectively infiltrating the tumor site, which further complicates treatment outcomes. Diverse innovative strategies have been suggested to surmount these barriers in the context of CRC. This comprehensive review endeavors to meticulously elucidate an exhaustive and detailed evaluation of the prevailing and contemporary landscape concerning CAR-T cell therapy as it pertains to the intricate management of CRC, while simultaneously offering a thorough indication of the various risk factors and the associated prevalence that are intricately linked with the manifestation and progression of CRC.</p>","PeriodicalId":14152,"journal":{"name":"International Journal of Molecular and Cellular Medicine","volume":"14 2","pages":"777-792"},"PeriodicalIF":0.8,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12321304/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144789071","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SARS-CoV-2 ORF7 subgenomic RNA and Host IFN-β Expression in COVID-19 Hospitalized Patients with Different Prognosis. 不同预后的COVID-19住院患者SARS-CoV-2 ORF7亚基因组RNA和宿主IFN-β表达
IF 0.8
International Journal of Molecular and Cellular Medicine Pub Date : 2025-07-01 eCollection Date: 2025-01-01 DOI: 10.22088/IJMCM.BUMS.14.2.726
Akbar Zirakjou, Farzin Sadeghi, Arefeh Ebrahimian Shiadeh, Maryam Hatamibardar, Mohammad Ranaee, Hemmat Gholinia, Hossein Ghorbani
{"title":"SARS-CoV-2 ORF7 subgenomic RNA and Host IFN-β Expression in COVID-19 Hospitalized Patients with Different Prognosis.","authors":"Akbar Zirakjou, Farzin Sadeghi, Arefeh Ebrahimian Shiadeh, Maryam Hatamibardar, Mohammad Ranaee, Hemmat Gholinia, Hossein Ghorbani","doi":"10.22088/IJMCM.BUMS.14.2.726","DOIUrl":"10.22088/IJMCM.BUMS.14.2.726","url":null,"abstract":"<p><p>The worldwide spread of COVID-19, triggered by SARS-CoV-2, has highlighted how viral accessory proteins contribute significantly to bypassing host immune defenses and increasing illness severity. This study investigates the relationship between the levels of SARS-CoV-2 subgenomic RNA (sgRNA) for ORF7a and ORF7b and host interferon-beta (IFN-β) expression in hospitalized COVID-19 patients with different prognoses. Upper respiratory tract samples from 89 patients (49 with poor prognosis and 40 with good prognosis) were analyzed using quantitative real-time PCR to measure ORF7a, ORF7b, and IFN-β expression levels. The results revealed significantly higher expression of ORF7a and ORF7b in patients with poor prognosis compared to those with favorable outcomes (P < 0.001). Conversely, IFN-β expression was significantly reduced in the poor prognosis group (P < 0.001), suggesting a potential mechanism of immune suppression. Older age, underlying health conditions, and elevated levels of inflammatory biomarkers, such as CRP and D-dimer, were also associated with poorer outcomes. These findings underscore the potential role of ORF7 proteins in suppressing IFN-β signaling, contributing to disease severity. Targeting these viral proteins may offer promising therapeutic avenues to enhance antiviral responses and improve patient outcomes. The study was conducted from August 2022 to February 2022. Further research is warranted to better understand the interplay between viral immune evasion mechanisms and host responses across diverse patient populations.</p>","PeriodicalId":14152,"journal":{"name":"International Journal of Molecular and Cellular Medicine","volume":"14 2","pages":"726-735"},"PeriodicalIF":0.8,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12321312/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144789072","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Osteogenic potential of human dental pulp stem cells, and human dermal fibroblasts exposed hydroxyapatite nanoparticles: A comparative in vitro study. 暴露于羟基磷灰石纳米颗粒的人牙髓干细胞和人真皮成纤维细胞的成骨潜能:一项体外比较研究。
IF 0.8
International Journal of Molecular and Cellular Medicine Pub Date : 2025-07-01 eCollection Date: 2025-01-01 DOI: 10.22088/IJMCM.BUMS.14.2.656
Mohsen Naseri, Sepideh Sarfi, Mohammad Yahya Hanafi-Bojd, Ehsaneh Azaryan
{"title":"Osteogenic potential of human dental pulp stem cells, and human dermal fibroblasts exposed hydroxyapatite nanoparticles: A comparative in vitro study.","authors":"Mohsen Naseri, Sepideh Sarfi, Mohammad Yahya Hanafi-Bojd, Ehsaneh Azaryan","doi":"10.22088/IJMCM.BUMS.14.2.656","DOIUrl":"10.22088/IJMCM.BUMS.14.2.656","url":null,"abstract":"<p><p>This study aimed to evaluate the osteogenic response of human dermal fibroblasts (hDFs) and human dental pulp stem cells (hDPSCs) when exposed to hydroxyapatite nanoparticles (HA-NPs), which are commonly employed biomaterials in the field of bone regeneration. The sol-gel method was employed to synthesize HA-NPs. Cell viability was assessed using the MTT assay after 24 and 72 hours of exposure to HA-NPs. Osteogenic differentiation was assessed through Alizarin red S staining (ARS), alkaline phosphatase (ALP) activity assay, and quantitative real-time PCR (qPCR) to evaluate the expression levels of osteogenic markers, including BMP-2, VEGF-A, RUNX2, and IL-6. The HA-NPs had a nanorod shape, with dimensions of 17-29 nm in width and 62-89 nm in length. Both hDPSCs and hDFs demonstrated enhanced osteogenic potential when exposed to HA-NPs, as indicated by increased ARS staining for calcium deposition and elevated ALP activity. Gene expression analysis showed up-regulation of BMP-2 and VEGF-A and down-regulation of RUNX2 in both cell types. IL-6 expression markedly increased in hDFs but did not show significant changes in hDPSCs compared to the control group. The findings of this study suggest that HA-NPs may enhance the osteogenic capability of hDPSCs and hDFs. The results demonstrate that while fibroblasts exhibit some mineralization potential, hDPSCs are the most suitable cell type for bone regenerative applications.</p>","PeriodicalId":14152,"journal":{"name":"International Journal of Molecular and Cellular Medicine","volume":"14 2","pages":"656-665"},"PeriodicalIF":0.8,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12321310/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144789042","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SIRT1 and miR-34a as Potential Plasma Biomarkers in the Acute Phase of Ischemic Stroke. SIRT1和miR-34a作为缺血性卒中急性期潜在的血浆生物标志物
IF 0.8
International Journal of Molecular and Cellular Medicine Pub Date : 2025-07-01 eCollection Date: 2025-01-01 DOI: 10.22088/IJMCM.BUMS.14.2.714
Mitra Ansari Dezfouli, Moslem Esmati, Seyed Khalil Rashidi, Shahram Rafie, Mohammad-Reza Mahmoudian-Sani, Ebrahim Behzad
{"title":"SIRT1 and miR-34a as Potential Plasma Biomarkers in the Acute Phase of Ischemic Stroke.","authors":"Mitra Ansari Dezfouli, Moslem Esmati, Seyed Khalil Rashidi, Shahram Rafie, Mohammad-Reza Mahmoudian-Sani, Ebrahim Behzad","doi":"10.22088/IJMCM.BUMS.14.2.714","DOIUrl":"10.22088/IJMCM.BUMS.14.2.714","url":null,"abstract":"<p><p>Stroke is the major cause of disability and mortality worldwide. Identification of molecular biomarkers in the early hours after stroke is important in terms of both diagnostic and therapeutic applications. miR-34a, a highly expressed miRNA, is involved in many pathological mechanisms in the central nervous system. This miRNA targets sirtuin 1 (SIRT1) gene. Here, the efficacy of miR-34a/SIRT1 axis as a potential biomarker in the acute phase of ischemic stroke has been evaluated. 100 patients (in the first 12 hours after ischemic stroke) and 100 healthy subjects were examined. miR-34a expression level was assessed using real-time polymerase chain reaction and SIRT1 level was measured using Enzyme-linked immunosorbent assay. Stroke etiology and infarct size were investigated in the patients. The National Institutes of Health Stroke Scale (NIHSS) was also evaluated. Compared to the healthy controls, ischemic stroke patients showed increased miR-34a expression (P < 0.0001) and decreased SIRT1 levels (P < 0.0001). The levels of miR-34a and SIRT1 showed significant differences among various subtypes of stroke etiology and infarct size. The baseline NIHSS values were correlated negatively with SIRT1 (r=-0.89) and positively with miR-34a (r=0.81). Our results suggested that dysregulation in miR-34a/SIRT1 may be a potential biomarker in occurrence and severity of ischemic stroke.</p>","PeriodicalId":14152,"journal":{"name":"International Journal of Molecular and Cellular Medicine","volume":"14 2","pages":"714-725"},"PeriodicalIF":0.8,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12321313/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144789073","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Combined Methylation Analysis of SDC2 and TFPI2 in Plasma: A Noninvasive Liquid Biopsy Approach for Early Detection of Colorectal Polyp. 血浆中SDC2和TFPI2的联合甲基化分析:一种无创液体活检方法用于结肠直肠息肉的早期检测。
IF 0.8
International Journal of Molecular and Cellular Medicine Pub Date : 2025-07-01 eCollection Date: 2025-01-01 DOI: 10.22088/IJMCM.BUMS.14.2.646
Milad Khabbazpour, Mohammad Heiat, Ashraf Karbasi, Majid Zaki-Dizaji
{"title":"Combined Methylation Analysis of SDC2 and TFPI2 in Plasma: A Noninvasive Liquid Biopsy Approach for Early Detection of Colorectal Polyp.","authors":"Milad Khabbazpour, Mohammad Heiat, Ashraf Karbasi, Majid Zaki-Dizaji","doi":"10.22088/IJMCM.BUMS.14.2.646","DOIUrl":"10.22088/IJMCM.BUMS.14.2.646","url":null,"abstract":"<p><p>Early detection is crucial for improving survival rates in colorectal cancer (CRC). This study evaluates the non-invasive diagnosis of polyps by assessing the methylation status of the TFPI2 and SDC2 genes in plasma. This study enrolled 27 individuals with low-risk polyps (LRP), 27 with high-risk polyps (HRP), and 27 healthy controls. The quantitative methylation levels of TFPI2 and SDC2 genes were analyzed in plasma cell-free DNA (cfDNA) using the methylation-quantification endonuclease-resistant DNA (MethyQESD) method. Increased methylation percentages of both TFPI2 (TFPI2_1 and TFPI2_2) and SDC2 (SDC2_2) were observed in individuals with LRP and HRP. The combination of SDC2 and TFPI2 yielded an Area Under the Curve (AUC) of 0.732 (95% CI 0.78 to 0.96, p=0.001) with a sensitivity of 66% (95% CI 46% - 82%) and specificity of 77% (95 CI 56% - 91%) for LRP. For HRP, the AUC was 0.890 (95% CI 0.596 to 0.843, p<0.001) with a sensitivity of 70% (95% CI 51% - 84%) and specificity of 92% (95 CI 75% - 99%). The combined assessment of SDC2 and TFPI2 methylation presents a potential approach for the early non-invasive detection of CRC and its associated precancerous lesions.</p>","PeriodicalId":14152,"journal":{"name":"International Journal of Molecular and Cellular Medicine","volume":"14 2","pages":"646-655"},"PeriodicalIF":0.8,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12321302/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144789035","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Navigating the Molecular Signaling: Deciphering Cancer Stem Cell Self-Renewal Pathways. 导航分子信号:解读癌症干细胞自我更新途径。
IF 0.8
International Journal of Molecular and Cellular Medicine Pub Date : 2025-07-01 eCollection Date: 2025-01-01 DOI: 10.22088/IJMCM.BUMS.14.2.753
Seyed Nasser Hoseinian, Mohammad Saeedi, Mohammad Erfan Saravani, Sepideh Zenoozi, Fatemeh Mehranfar, Amin Pouyan
{"title":"Navigating the Molecular Signaling: Deciphering Cancer Stem Cell Self-Renewal Pathways.","authors":"Seyed Nasser Hoseinian, Mohammad Saeedi, Mohammad Erfan Saravani, Sepideh Zenoozi, Fatemeh Mehranfar, Amin Pouyan","doi":"10.22088/IJMCM.BUMS.14.2.753","DOIUrl":"10.22088/IJMCM.BUMS.14.2.753","url":null,"abstract":"<p><p>Cancer stem cells (CSCs) are a subset of cells within tumors that exhibit stem cell-like characteristics, including the ability to self-renew and differentiate. CSCs are the cause of carcinogenesis and tumorigenesis. The expression of cell surface markers, which varies linked to the kind of tumor, is utilized to recognize CSCs. An essential part of tumor invasion and metastasis is played by CSCs. Numerous investigations have been carried out to find distinguished markers and different phenotypes of CSCs, which are especially crucial for identifying and separating this subset of cells. It was discovered that the regulation of CSCs involves a multitude of signaling pathways. These cells are determined by their ability to self-renewal pathways such as Wnt/β-catenin, JAK/STAT3, PTEN/PI3-K/Akt, and Hedgehog, their surface biomarkers, and their resistance to many drugs. Aberrant activation of these signaling pathways is associated with cell growth. Thus, focusing on CSCs is seen to be a viable anti-cancer treatment approach. It is encouraging that CSCs' self-renewal pathways present a viable target for changing their survival tactics and limiting their capacity to proliferate tumors. This study highlights the characterization and investigation of CSC self-renewal pathways, also discusses potential targeted therapy for CSC, and gives a summary of the significant factors and pathways that adjust CSC formation.</p>","PeriodicalId":14152,"journal":{"name":"International Journal of Molecular and Cellular Medicine","volume":"14 2","pages":"735-776"},"PeriodicalIF":0.8,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12321308/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144789039","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dose-Dependent Modulation of NMDA Receptors: Neuroprotective Mechanisms against Oxidative Stress in Hippocampal Neurons. NMDA受体的剂量依赖性调节:海马神经元抗氧化应激的神经保护机制。
IF 0.8
International Journal of Molecular and Cellular Medicine Pub Date : 2025-07-01 eCollection Date: 2025-01-01 DOI: 10.22088/IJMCM.BUMS.14.2.682
Marjan Nikbakhtzadeh, Asal Behboudian, Maryam Mohammadnia, Zahra Yaghoobi, Saereh Hosseindoost, Afshin Kheradmand, Ghorbangol Ashabi
{"title":"Dose-Dependent Modulation of NMDA Receptors: Neuroprotective Mechanisms against Oxidative Stress in Hippocampal Neurons.","authors":"Marjan Nikbakhtzadeh, Asal Behboudian, Maryam Mohammadnia, Zahra Yaghoobi, Saereh Hosseindoost, Afshin Kheradmand, Ghorbangol Ashabi","doi":"10.22088/IJMCM.BUMS.14.2.682","DOIUrl":"10.22088/IJMCM.BUMS.14.2.682","url":null,"abstract":"<p><p>N-Methyl-D-Aspartate (NMDA) receptors are involved in synaptic plasticity and neuronal communication. They have various responses to oxidative stress based on the dosage of agonists or antagonists that may be applied. This study focuses on modulation of NMDA receptors in primary hippocampal neurons in oxidative stress condition to understand the effects of NMDA receptor activation and inhibition. In our experiments, primary hippocampal neurons were treated with NMDA and MK-801 to assess their effect on cell viability and apoptosis. Oxidative stress was induced at different concentrations, to evaluate NMDA receptor activity and the neuroprotective effects of MK-801. Apoptosis rates were specified by applying flow cytometry, and assaying caspase-3 activity. Intracellular calcium levels were monitored using fluorescent dye Fura-2 AM. NMDA at 200 μM significantly prevented the cytotoxic effect induced by H<sub>2</sub>O<sub>2</sub> (P<0.001). MK-801 with concentrations of 5 to 20 μM, could reverse the cytotoxic effect of H<sub>2</sub>O<sub>2</sub>. As a result, it significantly inhibited the toxicity of H<sub>2</sub>O<sub>2</sub> on neuronal cells (P<0.001), while 40 μM could not reverse its effects. NMDA (200 μM) increased neuronal survival to 88.3% in the presence of H<sub>2</sub>O<sub>2</sub> and prevented apoptosis. MK-801 (5 μM) also elevated cell survival to 87.2%. Treatment with NMDA (200 µM) + H<sub>2</sub>O<sub>2</sub> also did not show any changes in the Fura-2AM fluorescence compared to the H<sub>2</sub>O<sub>2</sub> group (P>0.05). However, MK-801+ H<sub>2</sub>O<sub>2</sub> reduced the effects of H<sub>2</sub>O<sub>2</sub> on the fluorescence ratio and calcium influx considerably in comparison with the H<sub>2</sub>O<sub>2</sub> group (P<0.01). Treatment with MK-801 (5 μM) effectively mitigated the effects of H<sub>2</sub>O<sub>2</sub> on caspase-3 activity compared to the H<sub>2</sub>O<sub>2</sub> group (P<0.001). Importantly, the dose-dependent effects of NMDA receptors offer a new path into finding therapeutic strategies for neurodegenerative diseases <b><i>.</i></b></p>","PeriodicalId":14152,"journal":{"name":"International Journal of Molecular and Cellular Medicine","volume":"14 2","pages":"682-693"},"PeriodicalIF":0.8,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12321311/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144789036","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anti-tumor Effects of Curcumin and ABT-737 in Combination Therapy for Glioblastoma in Vivo. 姜黄素与ABT-737联合治疗胶质母细胞瘤的体内抗肿瘤作用。
IF 1.5
International Journal of Molecular and Cellular Medicine Pub Date : 2025-01-01 DOI: 10.22088/IJMCM.BUMS.14.1.552
Zahra Sadat Miri, Hossein Bagheri, Alireza Amani, Hadi Karami
{"title":"Anti-tumor Effects of Curcumin and ABT-737 in Combination Therapy for Glioblastoma in Vivo.","authors":"Zahra Sadat Miri, Hossein Bagheri, Alireza Amani, Hadi Karami","doi":"10.22088/IJMCM.BUMS.14.1.552","DOIUrl":"10.22088/IJMCM.BUMS.14.1.552","url":null,"abstract":"<p><p>The resistance of tumor cells to ABT-737 can be attributed to alterations in the equilibrium of Bcl-2 family proteins. In this study, the effect of curcumin on the Mcl-1expression and the sensitivity of glioblastoma cells to ABT-737 were examined. Trypan blue assay and colony formation assay were performed to explore the effects of treatments on cell proliferation. MTT assay was performed to measure cytotoxicity. Cell migration was determined using a wound healing assay. Cell apoptosis was measured by Hoechst 33342 staining, ELISA cell death, and caspase-3 activity assay. The expression levels of Mcl-1 mRNA were also tested by qRT-PCR. Our results revealed that combination therapy significantly lowered the IC<sub>50</sub> value and synergistically decreased the colony formation and migration, cell survival and growth of glioblastoma cells compared with curcumin or ABT-737 alone. Treatment with curcumin clearly inhibited the expression of Mcl-1 mRNA. Moreover, suppression of Mcl-1 mRNA by curcumin was associated with enhancement of apoptosis induced by ABT-737. In conclusion, curcumin has the ability to inhibit the cell proliferation and migration, and activate the intrinsic pathway of apoptosis. Moreover, it can enhance the sensitivity of glioblastoma cells to ABT-737 by suppressing the expression of Mcl-1.</p>","PeriodicalId":14152,"journal":{"name":"International Journal of Molecular and Cellular Medicine","volume":"14 1","pages":"552-566"},"PeriodicalIF":1.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11927151/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143691654","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书